Salomon & Ludwin’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Salomon & Ludwin's LLY Position: Q2 2026 in Review
Salomon & Ludwin reduced its Eli Lilly (LLY) stake by 3.1% in Q2 2026, selling an estimated $54.2K and leaving 1,638 shares worth $1.95M. The position accounts for 0.16% of the portfolio, ranked #73.
Salomon & Ludwin first reported a position in LLY in Q1 2019 and has held it in 22 quarters since. The position peaked at $19.1M in Q1 2024. 4,626 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Salomon & Ludwin held 1,638 shares of Eli Lilly worth $1.95M as of Q2 2026.
- Salomon & Ludwin sold 53 Eli Lilly shares in Q2 2026, an estimated $54.2K.
- Eli Lilly made up 0.16% of Salomon & Ludwin's portfolio in Q2 2026, its #73 holding.
- Salomon & Ludwin first reported a position in Eli Lilly in Q1 2019 and has held it in 22 quarters since.
- Salomon & Ludwin's Eli Lilly position peaked at $19.1M in Q1 2024.
- 4,626 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Salomon & Ludwin's 13F filing for Q2 2026, filed 7 Aug 2026.